Coronavirus News

Medindia's Press Release’ section provides the latest press release on Coronavirus from across the world for the global audience. This page links to 2410 Coronavirus press releases.

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza

PR Newswire GAITHERSBURG, Md., Dec. 10, 2024 GAITHERSBURG, Md., Dec. 10, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the first ...

PrecisePoint JV, LLC Wins Contract to Support the Centers for Disease Control and Prevention's COVID-19 Administration Reporting System (CARS) Help Desk 2.0

PR Newswire ROCKVILLE, Md., Dec. 5, 2024 The joint venture (JV) partnership between Precise Software Solutions, LLC and Turning Point Global Solutions, L.L.C. (TurningPoint) has been awarded a five-year contract with the Centers for Disease ...

Long COVID Brain Fog Linked to Lung Function

PR Newswire CHICAGO, Nov. 26, 2024 CHICAGO, Nov. 26, 2024 /PRNewswire/ -- In patients with long COVID, lower pulmonary gas exchange may be associated with impaired cognitive function, according to a study being presented next week at ...

Healthcare Cloud Computing Market to Grow by USD 98.6 Billion from 2024-2028, as Integrated Services Drive Demand with AI-Powered Market Evolution - Technavio

PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global healthcare cloud computing market size is estimated to grow by USD 98.6 billion from 2024-2028, ...

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

PR Newswire GAITHERSBURG, Md., Nov. 11, 2024 GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and ...

Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development

PR Newswire WEXFORD, Pa., Nov. 7, 2024 Study results demonstrate the safety and feasibility of adoptive immunotherapy using allogeneic off-the-shelf NK cells in hospitalized patients with COVID at high risk for progression of disease ...

Study reveals stubborn mistrust in COVID-19 vaccine science

PR Newswire NEW YORK, Nov. 4, 2024 NEW YORK, Nov. 4, 2024 /PRNewswire/ -- A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) ...

COVID-19 Sharply Boosts Risk for Blood-Fat Disorders

PR Newswire BRONX, N.Y., Nov. 1, 2024 BRONX, N.Y., Nov. 1, 2024 /PRNewswire/ -- A new study led by researchers at Albert Einstein College of Medicine involving more than 200,000 adults found that the COVID-19 pandemic caused a 29% increase ...

Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test

PR Newswire HOUSTON, Oct. 8, 2024 Healgen Rapid Check® COVID-19/Flu A&B Antigen Test was supported through the Independent Test Assessment Program (ITAP), a National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech ...

FDA Authorizes Marketing of First Home Flu and COVID-19 Combination Test Outside of Emergency Use Authorities

PR Newswire SILVER SPRING, Md., Oct. 7, 2024 SILVER SPRING, Md., Oct. 7, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test. The test, ...

First Prev
1
2
3
4
5
6
7
8
9
10
Next
Last